BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 2, 2005
View Archived Issues
XenoPort Partners Asian Rights To Lead Product With Astellas
XenoPort Inc. could receive more than $85 million after agreeing to out-license Asian rights to its lead product candidate, XP13512, to Astellas Pharma Inc. (BioWorld Today)
Read More
Rigel's Rhinitis Drug Misses Primary Endpoint In Phase II
Read More
Crucell Acquiring Berna Biotech In US$449M All-Share Takeover
Read More
Lexicon, Genentech Sign $25M Drug Discovery Deal Expansion
Read More
Other News To Note
Read More